Aquestive Therapeutics to Hold Virtual-Only Annual Meeting of Stockholders - Seite 3

Voting Shares

If you have not already voted your shares in advance, you will be able to vote your shares electronically during the Annual Meeting by clicking on the “Cast Your Vote” link on the meeting center site. Whether or not you plan to attend the Annual Meeting, stockholders are urged to vote and submit their proxy in advance of the Annual Meeting by one of the methods described in the proxy materials for the Annual Meeting previously distributed.

The Proxy Card and Voting Instruction Form (or Notice of Internet Availability of Proxy Materials) included with the previously distributed proxy materials will not be updated to reflect the change in location and may continue to be used to vote shares in connection with the Annual Meeting.

List of Stockholders

A list of stockholders of record will be available during the Annual Meeting for inspection by stockholders for any legally valid purpose related to the Annual Meeting at www.meetingcenter.io/236154631. 

Attending the Annual Meeting as a Guest

If you would like to enter the meeting as a guest in listen-only mode, click on the “I am a guest” button after entering the meeting center at www.meetingcenter.io/236154631 and enter the information requested. Please note you will not have the ability to ask questions or vote during the meeting if you participate as a guest.

Technical Support

Online access to the virtual meeting will open at 9:15 a.m., Eastern Time on Tuesday, June 16, 2020, to allow you time to log in and test your device’s audio system.  The Company encourages you to access the meeting in advance of the meeting start time.  If you need technical support after you access the meeting center, click the “Help” link on the upper right-hand corner of the broadcast screen.

About Aquestive Therapeutics

Aquestive Therapeutics is a pharmaceutical company that applies innovative technology to solve therapeutic problems and improve medicines for patients. Aquestive is advancing a late-stage proprietary product pipeline to treat CNS conditions and provide alternatives to invasively administered standard of care therapies. The Company also collaborates with other pharmaceutical companies to bring new molecules to market using proprietary, best-in-class technologies, like PharmFilm, and has proven capabilities for drug development and commercialization.

PharmFilm and the Aquestive logo are registered trademarks of Aquestive Therapeutics, Inc.

Investor Contact:
Stephanie Carrington
[e-mail]
646-277-1282